|
ELP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86550000003116E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54493999999783E-05 |
| Normal-vs-Stage2 |
1.156910E-03 |
| Normal-vs-Stage3 |
8.821900E-03 |
| Normal-vs-Stage4 |
2.591600E-04 |
| Stage1-vs-Stage2 |
8.452200E-01 |
| Stage1-vs-Stage3 |
6.183800E-01 |
| Stage1-vs-Stage4 |
4.972600E-01 |
| Stage2-vs-Stage3 |
7.490200E-01 |
| Stage2-vs-Stage4 |
5.016600E-01 |
| Stage3-vs-Stage4 |
4.059200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.00530000005195E-06 |
| Normal-vs-AfricanAmerican |
1.258560E-03 |
| Normal-vs-Asian |
6.379000E-01 |
| Caucasian-vs-AfricanAmerican |
4.497400E-01 |
| Caucasian-vs-Asian |
4.078800E-01 |
| AfricanAmerican-vs-Asian |
5.127600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.22120000357296E-08 |
| Normal-vs-Female |
7.908200E-02 |
| Male-vs-Female |
2.152200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.008000E-04 |
| Normal-vs-Extreme_Weight |
4.98609999999289E-06 |
| Normal-vs-Obese |
1.758510E-03 |
| Normal-vs-Extreme_Obese |
2.354800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.994200E-01 |
| Normal_Weight-vs-Obese |
3.208200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.664800E-01 |
| Extreme_Weight-vs-Obese |
3.047000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.834000E-01 |
| Obese-vs-Extreme_Obese |
9.697600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.257970E-01 |
| Normal-vs-Age(41-60Yrs) |
6.760800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.73730000052608E-07 |
| Normal-vs-Age(81-100Yrs) |
1.600400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.444400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.322000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.622000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.715600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.410200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.498620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.044750E-04 |
| Normal-VS-Type2 PRCC |
6.10439999999546E-05 |
| Normal-VS-KIRP CIMP |
1.005400E-01 |
| Normal-VS-Unclassified PRCC |
1.844420E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.075200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.837000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.750400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.237400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.479000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.618600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.31359999999637E-05 |
| Normal-vs-N1 |
1.849520E-02 |
| Normal-vs-N2 |
1.60483999999128E-05 |
| N0-vs-N1 |
2.067200E-01 |
| N0-vs-N2 |
1.594360E-01 |
| N1-vs-N2 |
1.747900E-02 |
|
|
